Survival of patients with chronic kidney disease treated with radical cystectomy and risk factors of glomerular filtration rate loss following radical cystectomy: two …

RS Motlagh, A Ghoreifi, T Yanagisawa, T Kawada… - European Urology …, 2024 - Elsevier
Context There is no high-level evidence regarding the risk factors of glomerular filtration rate
(GFR) loss following radical cystectomy (RC) and survival outcomes of patients with chronic …

Nephron-sparing approaches in upper tract urothelial carcinoma: current and future strategies

WS Ham, JS Park, WS Jang, J Kim - Biomedicines, 2022 - mdpi.com
Upper tract urothelial carcinoma (UTUC) is a relatively rare cancer, and much of the
approach to treatment has been derived from strategies employed in treating bladder …

Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma

TH Kim, CU Lee, M Kang, HG Jeon, BC Jeong… - Scientific Reports, 2021 - nature.com
This study aims to compare oncologic and functional outcomes after radical
nephroureterectomy (RNU) and segmental ureterectomy (SU) in patients with upper urinary …

Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study

K Shigeta, K Matsumoto, K Ogihara, T Murakami… - … Oncology: Seminars and …, 2022 - Elsevier
Objective The indications of neoadjuvant chemotherapy (NAC) for lymph node-positive
upper tract urothelial carcinoma (UTUC) have not been investigated regarding improved …

Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: a multicenter retrospective study

Y Okuyama, S Hatakeyama, R Tabata… - … Journal of Urology, 2023 - Wiley Online Library
Objective To assess the impact of radical nephroureterectomy on postoperative renal
function in patients with upper tract urothelial carcinoma (UTUC). Methods We …

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers

O Soma, S Hatakeyama, T Okamoto, N Fujita… - Medical Oncology, 2019 - Springer
We prospectively validate the efficacy of the frailty discriminant score (FDS) in individuals
with urological cancers, as there has been growing importance in evaluating frailty in clinical …

Impact of disagreement between two risk group models on prognosis in patients with metastatic renal-cell carcinoma

K Okita, S Hatakeyama, T Tanaka, Y Ikehata… - Clinical Genitourinary …, 2019 - Elsevier
Purpose To investigate the impact of the risk group disagreement between the Memorial
Sloan Kettering Cancer Center (MSKCC) and the International Metastatic Renal Cell …

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis

S Konishi, S Hatakeyama, T Tanaka, Y Ikehata… - Medical Oncology, 2019 - Springer
We aimed to compare oncological outcomes and safety of axitinib and sunitinib in patients
with treatment-naïve metastatic renal cell carcinoma (mRCC). We retrospectively evaluated …

Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: direct comparison from Taiwan‐Japan UTUC Collaboration Cohort

HL Luo, C Ohyama, S Hatakeyama… - … Journal of Urology, 2020 - Wiley Online Library
Objectives To carry out a comparison of upper urinary tract urothelial carcinoma
characteristics and behavior between patients in Taiwan and Japan. Methods A Taiwan …

Comparison of renal function after open radical cystectomy, extracorporeal robot assisted radical cystectomy, and intracorporeal robot assisted radical cystectomy

Z Lone, PB Murthy, JJH Zhang, KJ Ericson… - … Oncology: Seminars and …, 2021 - Elsevier
Purpose Renal function outcomes following robot-assisted radical cystectomy (RARC) have
not been well established. We sought to compare long-term renal function outcomes …